MedTrace Logo

Pilot Study of a Non-Invasive Central Venous Pressure Monitoring System in Children

NCT03160742 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2018-10-09

No results posted yet for this study

Summary

The goal of this research study is to determine the feasibility and accuracy of Mespere Life Science non-invasive central venous pressure monitoring system (Mespere VENUS 2000CVP system) in children with congenital heart disease (CHD).

Conditions

  • Central Venous Pressure

Interventions

DEVICE

Mespere VENUS 200CVP system

Non-invasive sensor placed on the neck

Sponsors & Collaborators

Principal Investigators

  • Kirsten Odegard, MD · Boston Children's Hospital

Eligibility

Min Age
12 Months
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-25
Primary Completion
2018-04-25
Completion
2018-09-14
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03160742 on ClinicalTrials.gov